News
1d
New Scientist on MSNHuman trials point the way towards an mRNA vaccine against HIVWe may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
A breakthrough in our understanding of mRNA delivery systems in the body may allow for more direct treatments for ...
A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
StockStory.org on MSN18h
Moderna Earnings: What To Look For From MRNABiotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.
An mRNA cancer vaccine triggered strong immune responses and improved treatment outcomes in mice, offering a new approach to ...
Stock index futures rose on Thursday, with Nasdaq futures leading the charge, as Meta and Microsoft impressed investors with ...
Moderna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, ...
Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid ...
What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results